Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French departments of internal medicine/infectious diseases, in 1995 and 1997

Clinical Infectious Diseases

Volumn 32, Issue 8, 2001, Pages 1207-1214

  Cacoub, Patrice ^a   Geffray, Loïk ^b   Rosenthal, Eric ^c   Perronne, Christian ^d   Veyssier, Pierre ^e   Raguin, Gilles ^f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Hôpital Robert Bisson   (India)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d RAYMOND POINCARÉ HOSPITAL   (France)

^e Hôpital de Compiègne   (France)

^f GROUPE HOSPITALIER DIACONESSES CROIX SAINT SIMON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CAUSE OF DEATH; DISEASE SEVERITY; FRANCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CARCINOMA, HEPATOCELLULAR; FEMALE; FRANCE; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 0035870873     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/319747     Document Type: Article

References (28)

1. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infection
2. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals
3. Seroprevalence of HBV, HCV and HDV hepatitis markers in 500 patients infected with the human immunodeficiency virus
4. Prevalence of hepatitis C in a chemically dependent population
5. Epidemiology of hepatitis C virus in Europe
6. Rapidly progressive nonA, nonB hepatitis in patients with human immunodeficiency virus infection
7. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study
8. Hepatitis C virus infection in patients infected with the human immunodeficiency virus
9. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis
10. Changing patterns of mortality across Europe in patients infected with HIV-1
11. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
12. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
13. Influence of hepatitis C virus infection on the mortality of antiretroviral treated patients with HIV disease
14. The natural history of chronic hepatitis C in haemophiliacs
15. Mortality from cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C
16. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users
17. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users
18. Chronic delta hepatitis: Is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infection?
19. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
20. Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV
21. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs
22. Lack of benefit of antiprotease inhibitors on HCV viremia in HIV-infected patients
23. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV
24. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy
25. Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects
26. Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy
27. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: An immune restoration disease?
28. Hepatitis C in France: A national survey in the departments of internal medicine and infectious diseases